| 摘要 |
The invention provides compounds of Formula (I): wherein R<SUB>1</SUB>-R<SUB>4 </SUB>have any of the values defined in the specification that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use, and methods and intermediates useful for preparing them.
|
